Shi Y - Search Results

1

Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study.

Xie T, Fan G, Tang L, Xing P, Shi Y. Xie T, et al. Among authors: shi y. Cancer Immunol Immunother. 2024 Dec 21;74(1):29. doi: 10.1007/s00262-024-03886-0. Cancer Immunol Immunother. 2024. PMID: 39708123 Free PMC article.

2

Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.

Huang L, Feng Y, Xie T, Zhu H, Tang L, Shi Y. Huang L, et al. Among authors: shi y. BMC Cancer. 2023 Apr 5;23(1):312. doi: 10.1186/s12885-023-10797-3. BMC Cancer. 2023. PMID: 37020179 Free PMC article.

3

[Association between different EGFR mutation status and survival in pemetrexed-based chemotherapy for advanced non-small cell lung cancer].

Jia B, He XH, Yang S, Wang ZP, Li JL, Wang Y, Wang HY, Xing PY, Liu YT, Shi YK. Jia B, et al. Among authors: shi yk. Zhonghua Yi Xue Za Zhi. 2013 Dec;93(46):3659-62. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24534344 Chinese.

4

Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI.

Liu YT, Zhang K, Li CC, Hu XS, Jiang J, Hao XZ, Wang Y, Li JL, Xing PY, Yang S, Zhang X, Wang GQ, Cai SL, Shi YK. Liu YT, et al. Among authors: shi yk. J Cancer. 2019 Aug 28;10(21):5108-5113. doi: 10.7150/jca.33450. eCollection 2019. J Cancer. 2019. PMID: 31602263 Free PMC article.

5

[Clinical characteristics and treatment of desmoplastic small round cell tumor].

Xing PY, Shi YK, Feng FY, Qin Y, Liu P. Xing PY, et al. Among authors: shi yk. Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):139-42. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20403246 Review. Chinese.

6

Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer.

Xing PY, Li JL, Wang Y, Hao XZ, Wang B, Yang L, Shi YK, Zhang XR. Xing PY, et al. Among authors: shi yk. Chin J Cancer Res. 2013 Apr;25(2):200-5. doi: 10.3978/j.issn.1000-9604.2013.03.04. Chin J Cancer Res. 2013. PMID: 23592901 Free PMC article.

7

Analysis of clinicopathological features of the echinoderm microtubule-associated protein-like-4-anaplastic lymphoma kinase fusion gene in Chinese patients with advanced non-small-cell lung cancer.

Liu YT, Shi YK, Hao XZ, Wang L, Li JL, Han XH, Li D, Zhou YJ, Tang L. Liu YT, et al. Thorac Cancer. 2014 May;5(3):255-60. doi: 10.1111/1759-7714.12101. Epub 2014 Apr 22. Thorac Cancer. 2014. PMID: 26767009 Free PMC article.

8

Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer.

Liu YT, Han XH, Xing PY, Hu XS, Hao XZ, Wang Y, Li JL, Zhang ZS, Yang ZH, Shi YK. Liu YT, et al. Among authors: shi yk. J Thorac Dis. 2019 May;11(5):1779-1787. doi: 10.21037/jtd.2019.05.22. J Thorac Dis. 2019. PMID: 31285870 Free PMC article.

9

Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas.

Dong M, Ning ZQ, Xing PY, Xu JL, Cao HX, Dou GF, Meng ZY, Shi YK, Lu XP, Feng FY. Dong M, et al. Cancer Chemother Pharmacol. 2012 Jun;69(6):1413-22. doi: 10.1007/s00280-012-1847-5. Epub 2012 Feb 24. Cancer Chemother Pharmacol. 2012. PMID: 22362161 Clinical Trial.

10

[Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity].

Dong M, Xing PY, Liu P, Feng FY, Shi YK. Dong M, et al. Zhonghua Zhong Liu Za Zhi. 2010 Mar;32(3):208-11. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20450590 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,590 results

Search Page

Filters